MCK earnings call for the period ending June 30, 2020.
News & Analysis: McKesson
The drug-distributing giant appears more resilient to drug pricing pressure than investors had expected.
The pharmaceutical distributor more than doubled its bottom line.
Disappointing quarterly results and a downbeat outlook from management are weighing on share prices.